Novel protein, PPM1J-RHOC readthrough

The "novel protein, PPM1J-RHOC readthrough" (ENSG00000271810) is a predicted protein coding gene in humans defined as a readthrough transcript between the PPM1J and RHOC loci on chromosome 1[1][2][9][7]. Readthrough (also called co-transcription or chimeric transcript) genes are typically formed when transcription extends across adjacent genes, producing an mRNA that encodes a hybrid or fused protein from the two parental genes. Such events are often computationally predicted based on RNA-seq data but may not be biologically significant or stably expressed[9][7]. There is no information on the endogenous protein product, expression, or function of this readthrough in the literature or major gene/protein databases, and it is not recognized as an established therapeutic target or disease biomarker. Data and annotations are derived primarily from gene prediction algorithms and automated genome annotation; caution is warranted in biological interpretation as the existence and biological role of this protein have not been experimentally confirmed[1][9][7]. Key point: This is not a well-characterized protein, receptor, or enzyme. It is a predicted, computationally-annotated readthrough transcript with no established function, disease association, or relevance as a therapeutic target. If looking for validated targets, PPM1J or RHOC themselves (as individual proteins/genes) are better-supported entities[4][11].

Other names

Novel protein, PPM1J-RHOC readthroughENSG00000271810U3KQA9U3KQM5U3KQV3

None characterized (No drugs, no mechanism defined)